<html><head></head><body><h1>TriOxin Ear Drops</h1><p class="drug-subtitle"><b>Generic Name:</b> chloroxylenol, benzocaine and hydrocortisone acetate<br/>
<b>Dosage Form:</b> otic suspension<br/></p><ul class="nav-tabs nav-tabs-collapse nav-tabs-pill">
<li>Side Effects</li>
<li>Dosage</li>
<li><b class="nav-item here">Professional</b></li>
<li>Pregnancy</li>
<li class="nav-more">
More&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;svg aria-hidden="true" class="ddc-icon ddc-icon-down" focusable="false" height="16" viewBox="0 0 24 24" width="16" xmlns="http://www.w3.org/2000/svg"&gt;&lt;path d="M18.5 7.94L19.56 9 12 16.56 4.44 9 5.5 7.94l6.5 6.5z"&gt;&lt;/path&gt;&lt;/svg&gt;&lt;/body&gt;&lt;/html&gt;
</li>
</ul><p class="disclaimer">Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.</p><ul>
<li>Description</li>
<li>Clinical Pharmacology</li>
<li>Indications and Usage</li>
<li>Contraindications</li>
<li>Warnings</li>
<li>Precautions</li>
<li>Adverse Reactions/Side Effects</li>
<li class="ddc-toggle-hidden">Overdosage</li>
<li class="ddc-toggle-hidden">Dosage and Administration</li>
<li class="ddc-toggle-hidden">How Supplied/Storage and Handling</li>
</ul><p class="First"><span class="Bold">Rx Only</span></p><h2>TriOxin Ear Drops Description</h2><p class="First">Each 1 mL for otic administration contains:</p><p>Chloroxylenol . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 mg</p><p>Benzocaine . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 15 mg</p><p>Hydrocortisone Acetate . . . . . . . . . . . . . . . . . . . . . . . . . . 10 mg</p><p><span class="Bold">INACTIVE INGREDIENTS:</span> PEG-12 Glyceryl Dimyristate, Sodium Hydroxide, PEG-40 HCO, Purified Water, Acrylates/C10-30 Alkyl Acrylate Crosspolymer, Xanthan Gum, Potassium Sorbate, Isopropyl Alcohol.</p><p class="First"><span class="Bold">CLINICAL PHARMACOLOGY</span>1</p><p>TriOxin is effective both as an antibacterial and antifungal agent. The unique Hydrophilic Lipid based delivery system provides a suspension having an acid pH and a low surface tension, exerting a drying effect and allowing the medication to spread quickly to all contiguous surfaces, softening and reducing accumulated cerumen. Chloroxylenol is a halogenated phenol; non-toxic, non-corrosive, non-staining with high phenol coefficient. It may be applied directly to a wound and shows no chemical reactivity toward blood. TriOxin which contains hydrocortisone acetate is indicated when otitis is complicated by inflammation or to control itching. Benzocaine is a topical anesthetic with a low index of sensitization and toxicity.</p><h2>Indications and Usage for TriOxin Ear Drops</h2><p class="First">For the treatment of superficial infections of the external auditory canal complicated by inflammation caused by organisms susceptible to the action of the antimicrobial. May also be used to control itching in the auditory canal.</p><h2>Contraindications</h2><p class="First">Topical steroids are contraindicated in varicella, vaccinia and in patients sensitive to any of the components of this preparation. The preparation is not to be used for ophthalmic use and should not be applied in the external auditory canal of patients with perforated eardrums.</p><h2>Warnings</h2><p class="First">This preparation is not intended for ophthalmic or oral use. If accidental ingestion occurs, seek professional help. If irritation or sensitization occurs, promptly discontinue use of this preparation and institute other measures.</p><h2>Precautions</h2><h3>General</h3><p class="First">If a favorable response does not occur promptly, discontinue the use of this preparation until the infection is controlled by other appropriate measures. Although systemic side effects are not common with topical corticosteroids, the possibility of occurrence must be kept in mind, particularly when used for an extended period of time.</p><h3>USAGE IN PREGNANCY</h3><p class="First">The safety of topical steroid preparations during pregnancy has not been established. Therefore, they should not be used on pregnant patients.</p><h2>Adverse Reactions</h2><p class="First">The following adverse reactions with topical corticosteroids have been observed: itching, burning, irritation, dryness, folliculitis, hypertrichosis, acneform eruptions, hypopigmentations, perioral dermatitis, allergic contact dermatitis, maceration of the skin, secondary infection, skin atrophy, striae and miliaria.</p><h2>OVERDOSE</h2><p class="First">Topically applied corticosteroids can be absorbed in sufficient amount to produce systemic effects.</p><h2>TriOxin Ear Drops Dosage and Administration</h2><p class="First">SHAKE WELL BEFORE USING. The external auditory canal should be thoroughly cleansed and dried with a sterile cotton applicator. For adults, 4 to 5 drops of the suspension should be instilled into the affected ear 3 or 4 times daily. For infants and small children, 3 drops are suggested because of the smaller capacity of the ear canal. The patient should lie with the affected ear upward to instill the drops and this position maintained for 5 minutes to facilitate penetration of the drops into the ear canal. Repeat, if necessary, for the opposite ear.</p><h2>How is TriOxin Ear Drops Supplied</h2><p class="First">TriOxin Otic Suspension is supplied in 15mL amber glass bottles with dosage dropper and package insert. <span class="Bold">NDC 68025-041-15</span></p><p><span class="Bold">Rx Only</span></p><h3>Storage Conditions</h3><p class="First">Store at 20°-25°C (68°-77°F); excursions permitted to 15°-30°C (59°-86°F) [see USP Controlled Room Temperature].</p><p class="First"><span class="Bold">KEEP THIS AND ALL DRUGS OUT OF THE REACH OF CHILDREN.</span></p><p>05/09</p><p>Manufactured for<br/>
<span class="Bold">VERTICAL PHARMACEUTICALS, INC.</span><br/>
Sayreville, NJ 08872</p><p>Lipid Base Delivery System<br/>
<span class="Bold">QuSomes™</span><br/>
US Patent No. 6,610,322<br/>
US Patent No. 6,958,160<br/>
US Patent No. 7,150,883<br/>
Other patents may apply</p><h2>PRINCIPAL DISPLAY PANEL-Sample Label</h2><p class="First"><span class="Bold">NDC 68025-041-02<br/>
TriOxin<br/>
Rx Only</span><br/>
Otic Suspension</p><p><span class="Bold">(Chloroxylenol 1 mg, Benzocaine 15 mg,<br/>
Hydrocortisone Acetate10 mg)</span></p><p><span class="Bold">2 mL</span></p><h2>PRINCIPAL DISPLAY PANEL-Sample Carton</h2><p class="First"><span class="Bold">Physician Samples - not for resale</span></p><p><span class="Bold">TriOxin<br/>
Rx Only</span><br/>
Otic Suspension</p><p><span class="Bold">Each 1 mL for otic administration contains:</span></p><p>Chloroxylenol . . . . . . . . . . . . . . . 1 mg<br/>
Benzocaine . . . . . . . . . . . . . . . 15 mg<br/>
Hydrocortisone Acetate . . . . . 10 mg</p><p>Manufactured for:<br/>
<span class="Bold">VERTICAL</span><br/>
PHARMACEUTICALS, INC.</p><h2>PRINCIPAL DISPLAY PANEL-15 mL Carton</h2><p class="First"><span class="Bold">NDC 68025-041-15<br/>
15 mL bottle</span></p><p><span class="Bold">TriOxin<br/>
Rx Only</span><br/>
Otic Suspension</p><p><span class="Bold">Each 1 mL for otic administration contains:</span></p><p>Chloroxylenol . . . . . . . . . . . . . . . 1 mg<br/>
Benzocaine . . . . . . . . . . . . . . . 15 mg<br/>
Hydrocortisone Acetate . . . . . 10 mg</p><p>• Antibacterial and antifungal penetration<br/>
   using the QuSomes™ delivery system*</p><p>• Local anesthetic agent for pain relief*</p><p>• Local anti-inflammatory agent to<br/>
   reduce ear canal swelling*</p><p><span class="Italics">*Please see Package insert</span></p><p><span class="Bold Italics">SHAKE WELL BEFORE USING</span></p><p>Manufactured for:<br/>
<span class="Bold">VERTICAL</span><br/>
PHARMACEUTICALS, INC.</p><p>Lipid Base Delivery System<br/>
<span class="Bold">QuSomes™</span><br/>
US Patent No. 6,610,322<br/>
US Patent No. 6,958,160<br/>
US Patent No. 7,150,883<br/>
Other patents may apply</p><h2>More about Trioxin (benzocaine / chloroxylenol / hydrocortisone otic)</h2><ul class="more-resources-list more-resources-list-general">
<li>Side Effects</li>
<li>During Pregnancy</li>
<li>Dosage Information</li>
<li>Drug class: otic steroids with anti-infectives</li>
<li>FDA Alerts (1)</li>
</ul><h3>Professional resources</h3><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>Otitis Externa</li>
</ul><p class="ddc-disclaimer-link">Medical Disclaimer</p></body></html>